Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

By afschroeder • October 23, 2025

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart M. Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials. Cancer. 2025 Oct 15;131 Suppl 2:e70086. doi: 10.1002/cncr.70086. PMID: 41123586.

Tags: biostatistics, cancer clinical trials, Cedars Sinai DoM, General Internal Medicine, Hematology/Oncology, patient‐reported outcomes, Publications, toxicity, toxicity index, Treatment tolerability

Related Posts

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]

Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization

Levi A, Nasr A, Cui Y, Abbas AA, Arouchian TT, Coveler AL, Pierce TL, Anderson BT, Collisson E, Davelaar J, Lo SK, Gaddam S, Gong[...]

Longitudinal Repeated Protein Measurements in a Multiethnic Cohort Identify Novel Diabetes Biomarkers That Reveal Unique Disease Pathways

Chen ZZ, Mi MY, Barber J, Tiwari G, Adams CD, Deng S, Shin CY, Farrell L, Rao P, Cruz DE, Wilson JG, Sevilla-Gonzalez M, Chen[...]